Citi Upgrades Raptor Pharmaceuticals (RPTP) to Buy
Tweet
Share
E-mailGet Alerts RPTP Hot Sheet
Price: $9.00 --0%
Rating Summary:
6 Buy, 6 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 10 | New: 48
Rating Summary:
6 Buy, 6 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 10 | New: 48
Join SI Premium – FREE
Citi upgraded Raptor Pharmaceuticals (NASDAQ: RPTP) from Neutral to Buy.
For an analyst ratings summary and ratings history on Raptor Pharmaceuticals click here. For more ratings news on Raptor Pharmaceuticals click here.
Shares of Raptor Pharmaceuticals closed at $3.83 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cantor Fitzgerald Upgrades Omeros Corp. (OMER) to Overweight, 'We May Have Underestimated Yartemlea'
- Evercore ISI Upgrades The Macerich Company (MAC) to Outperform, 'improving balance sheet and accelerating FFO growth'
- Evercore ISI Upgrades CIENA (CIEN) to Outperform, 'we think the guide is conservative and we see a path to >40% growth'
Create E-mail Alert Related Categories
Hot Upgrades, UpgradesRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
